Overview
Hiromasa Hasegawa practices practicing medicine in Yamagata, Japan.
Hasegawa is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Heart Failure, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Atherosclerosis.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiromasa Hasegawa
Is Hiromasa Hasegawa a top-rated expert for Heart Failure?
MediFind is an objective health platform that identifies experts based on real-world data. Hiromasa Hasegawa is classified as an Advanced expert for Heart Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiromasa Hasegawa participate in research or clinical trials?
Yes. Hiromasa Hasegawa has published 13 articles and abstracts on conditions like Heart Failure. You can view a list of Hiromasa Hasegawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Heart FailureHasegawa isAdvanced. Learn about Heart Failure.
- Experienced
- AtherosclerosisHasegawa isExperienced. Learn about Atherosclerosis.
- Cardiomyopathy Due to Anthracyclines
- Doxorubicin-Induced CardiomyopathyHasegawa isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.